Our Product
Learn more about this FDA-approved product and its novel mechanism of action.
Verona Pharma announces the FDA approval of Ohtuvayre™ (ensifentrine) a new inhaled treatment.
PRO-OHT-1754-v1 06/2024
We welcome enquires from healthcare professionals.